JPS6072825A - アジユバント応答を起こすか又は免疫応答を刺激することのできる組成物 - Google Patents
アジユバント応答を起こすか又は免疫応答を刺激することのできる組成物Info
- Publication number
- JPS6072825A JPS6072825A JP59175877A JP17587784A JPS6072825A JP S6072825 A JPS6072825 A JP S6072825A JP 59175877 A JP59175877 A JP 59175877A JP 17587784 A JP17587784 A JP 17587784A JP S6072825 A JPS6072825 A JP S6072825A
- Authority
- JP
- Japan
- Prior art keywords
- endotoxin
- rde
- response
- composition
- stimulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52696783A | 1983-08-26 | 1983-08-26 | |
| US256967 | 1999-02-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6072825A true JPS6072825A (ja) | 1985-04-24 |
| JPH0556326B2 JPH0556326B2 (OSRAM) | 1993-08-19 |
Family
ID=24099553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59175877A Granted JPS6072825A (ja) | 1983-08-26 | 1984-08-25 | アジユバント応答を起こすか又は免疫応答を刺激することのできる組成物 |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS6072825A (OSRAM) |
| KR (1) | KR880002223B1 (OSRAM) |
| AT (1) | AT389228B (OSRAM) |
| AU (1) | AU554039B2 (OSRAM) |
| BE (1) | BE900377A (OSRAM) |
| CA (1) | CA1225592A (OSRAM) |
| CH (1) | CH660125A5 (OSRAM) |
| DE (2) | DE3448164C2 (OSRAM) |
| DK (1) | DK389384A (OSRAM) |
| ES (1) | ES8606883A1 (OSRAM) |
| FI (1) | FI843204L (OSRAM) |
| FR (1) | FR2550945B1 (OSRAM) |
| GB (1) | GB2147806B (OSRAM) |
| HU (1) | HU191713B (OSRAM) |
| IL (1) | IL72675A (OSRAM) |
| IN (1) | IN157910B (OSRAM) |
| IT (1) | IT1177974B (OSRAM) |
| NL (1) | NL192326C (OSRAM) |
| NO (1) | NO843243L (OSRAM) |
| NZ (1) | NZ209233A (OSRAM) |
| SE (1) | SE8404090L (OSRAM) |
| ZA (1) | ZA846309B (OSRAM) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6310736A (ja) * | 1986-04-15 | 1988-01-18 | リビ、イミュノケム、リサ−チ、インコ−ポレ−テッド | 免疫学的アジュバント |
| JPS6322029A (ja) * | 1986-04-15 | 1988-01-29 | リビ、イミユノケム、リサ−チ、インコ−ポレ−テツド | 多糖類ワクチン用免疫学的アジユバント |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4629722A (en) * | 1984-07-12 | 1986-12-16 | Ribi Immunochem Research, Inc. | Method of inhibiting the onset of acute radiation syndrome |
| DE10115310A1 (de) * | 2001-03-28 | 2002-10-10 | Nodar A Daniela | Bakteriophagen-Präparation |
| KR100868443B1 (ko) * | 2002-05-27 | 2008-11-11 | 주식회사 포스코 | 폭과 길이가 가변 조정되는 런치박스 제작장치 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4861619A (OSRAM) * | 1971-11-19 | 1973-08-29 | ||
| JPS4868729A (OSRAM) * | 1971-12-24 | 1973-09-19 | ||
| JPS5132794A (en) * | 1974-06-20 | 1976-03-19 | Anvar | Koshuyokoirusu oyobi ajubantokatsuseiojusuru maikobakuteriumufurakushonnoseiseiho |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2393065A1 (fr) * | 1977-05-31 | 1978-12-29 | Merieux Inst | Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis |
| US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
-
1984
- 1984-08-10 CA CA000460820A patent/CA1225592A/en not_active Expired
- 1984-08-13 DK DK389384A patent/DK389384A/da not_active Application Discontinuation
- 1984-08-14 ZA ZA846309A patent/ZA846309B/xx unknown
- 1984-08-14 IN IN567/CAL/84A patent/IN157910B/en unknown
- 1984-08-14 ES ES535124A patent/ES8606883A1/es not_active Expired
- 1984-08-14 IL IL72675A patent/IL72675A/xx not_active IP Right Cessation
- 1984-08-14 FI FI843204A patent/FI843204L/fi not_active Application Discontinuation
- 1984-08-14 NO NO843243A patent/NO843243L/no unknown
- 1984-08-14 SE SE8404090A patent/SE8404090L/xx not_active Application Discontinuation
- 1984-08-14 GB GB08420612A patent/GB2147806B/en not_active Expired
- 1984-08-15 NZ NZ209233A patent/NZ209233A/en unknown
- 1984-08-16 NL NL8402515A patent/NL192326C/nl not_active IP Right Cessation
- 1984-08-17 BE BE0/213506A patent/BE900377A/fr not_active IP Right Cessation
- 1984-08-21 AU AU32215/84A patent/AU554039B2/en not_active Expired
- 1984-08-21 CH CH4001/84A patent/CH660125A5/de not_active IP Right Cessation
- 1984-08-23 FR FR8413133A patent/FR2550945B1/fr not_active Expired
- 1984-08-23 HU HU843169A patent/HU191713B/hu unknown
- 1984-08-23 DE DE3448164A patent/DE3448164C2/de not_active Expired
- 1984-08-23 DE DE19843431058 patent/DE3431058A1/de active Granted
- 1984-08-24 IT IT48757/84A patent/IT1177974B/it active
- 1984-08-25 JP JP59175877A patent/JPS6072825A/ja active Granted
- 1984-08-25 KR KR1019840005189A patent/KR880002223B1/ko not_active Expired
- 1984-08-27 AT AT0273384A patent/AT389228B/de not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4861619A (OSRAM) * | 1971-11-19 | 1973-08-29 | ||
| JPS4868729A (OSRAM) * | 1971-12-24 | 1973-09-19 | ||
| JPS5132794A (en) * | 1974-06-20 | 1976-03-19 | Anvar | Koshuyokoirusu oyobi ajubantokatsuseiojusuru maikobakuteriumufurakushonnoseiseiho |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6310736A (ja) * | 1986-04-15 | 1988-01-18 | リビ、イミュノケム、リサ−チ、インコ−ポレ−テッド | 免疫学的アジュバント |
| JPS6322029A (ja) * | 1986-04-15 | 1988-01-29 | リビ、イミユノケム、リサ−チ、インコ−ポレ−テツド | 多糖類ワクチン用免疫学的アジユバント |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MORTON et al. | Immunological aspects of neoplasia: A rational basis for immunotherapy | |
| JPS58222025A (ja) | 精製無毒化エンドトキシンを含有する抗腫瘍組成物 | |
| FI76494B (fi) | Foerfarande foer framstaellning av renat, detoxifierat endotoxin. | |
| JPS58222027A (ja) | 精製無毒化エンドトキシンを含有する抗腫瘍組成物 | |
| WO2016165632A1 (zh) | 一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用 | |
| JPH01163130A (ja) | 腫瘍抗原およびアジュバントを含有するワクチン | |
| Alsaiari et al. | Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer | |
| JP2018516256A (ja) | 治療用ワクチンとしての使用のためのナノ粒子 | |
| JPS6072825A (ja) | アジユバント応答を起こすか又は免疫応答を刺激することのできる組成物 | |
| CN119633108B (zh) | 基于细胞焦亡诱导的mRNA疫苗佐剂及其应用 | |
| CN102898508B (zh) | 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途 | |
| CN116271090B (zh) | 一种具有tlr9激动剂活性的dna纳米笼及其在制备抗肿瘤药物中的应用 | |
| JP7772429B2 (ja) | 抗膵臓がんのワクチン、及びその医薬的使用 | |
| JP2025537428A (ja) | 標的化ナノスケール粒子、標的化細胞並びにその製造方法及び用途 | |
| Goldstein et al. | Experimental chemotherapy studies. VII. The effect of alkylation on the in vitro thymidine-incorporating system of Lettré-Ehrlich cells | |
| WO2014114254A1 (zh) | 饱和胺类化合物在制备抗辐射损伤及促进辐射损伤组织再生修复药物中的应用 | |
| WO2013155890A1 (zh) | 一种抗原组合物及其制备方法和用途以及肿瘤疫苗 | |
| CN115246870A (zh) | 活化的树突细胞及其在治疗癌症中的应用 | |
| WO2009135614A2 (en) | Use of a virus regimen for the treatment of diseases | |
| CN111012904A (zh) | 一种免疫复合物及其制备方法和用途 | |
| Glaser et al. | Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin | |
| CA3143364C (en) | .beta.-glucan composition and use therefor | |
| WO1994006820A1 (en) | Leukinferon preparation | |
| CN121401233A (zh) | 一种基于nk细胞膜包裹碳酸锰的免疫增敏ire治疗平台 | |
| US3574828A (en) | Method of obtaining anti-lymphoma antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |